Medical injector

Magome , et al. October 28, 2

Patent Grant D716442

U.S. patent number D716,442 [Application Number D/392,093] was granted by the patent office on 2014-10-28 for medical injector. This patent grant is currently assigned to Sanofi-Aventis Deutschland GmbH. The grantee listed for this patent is Shinichiro Magome, Chitose Orii, Rieko Yamada. Invention is credited to Shinichiro Magome, Chitose Orii, Rieko Yamada.


United States Patent D716,442
Magome ,   et al. October 28, 2014

Medical injector

Claims

CLAIM The ornamental design for the medical injector, as shown and described.
Inventors: Magome; Shinichiro (Tokyo, JP), Yamada; Rieko (Tokyo, JP), Orii; Chitose (Tokyo, JP)
Applicant:
Name City State Country Type

Magome; Shinichiro
Yamada; Rieko
Orii; Chitose

Tokyo
Tokyo
Tokyo

N/A
N/A
N/A

JP
JP
JP
Assignee: Sanofi-Aventis Deutschland GmbH (Frankfurt am Main, DE)
Appl. No.: D/392,093
Filed: May 17, 2011

Foreign Application Priority Data

Dec 6, 2010 [EM] 001789967-0001
Current U.S. Class: D24/113
Current International Class: 2402
Field of Search: ;D24/108,112-114,130,133,138,186,104,127,152,144,146,147 ;606/181,182,185,205,142 ;604/232,187,158,164.08,192,263,163,181,184,198,227,229 ;433/80 ;D19/35,36,41,43-57

References Cited [Referenced By]

U.S. Patent Documents
2398544 April 1946 Lockhart
3045593 July 1962 Petterson
3254836 June 1966 Corpian
4637403 January 1987 Garcia et al.
D289424 April 1987 Huang
4973318 November 1990 Holm et al.
D324070 February 1992 Suzuki
5334144 August 1994 Alchas et al.
D368961 April 1996 Himbert et al.
5569214 October 1996 Chanoch
D390872 February 1998 Sunaga
D414201 September 1999 Larson et al.
D426299 June 2000 Bydlon et al.
D426572 June 2000 Salemme et al.
6110149 August 2000 Klitgaard et al.
6277099 August 2001 Strowe et al.
D451138 November 2001 Rosenbaum
D462760 September 2002 Ahlgrim et al.
6454746 September 2002 Bydlon et al.
D479602 September 2003 Bainton
D479747 September 2003 Bainton
D479748 September 2003 Tyce
D482122 November 2003 Cohn et al.
D482724 November 2003 Nishida
D483067 December 2003 Takanashi
D492027 June 2004 Tyce et al.
D492405 June 2004 Bainton
D499485 December 2004 Tyce
D501253 January 2005 Bainton
D502739 March 2005 Shova et al.
D503477 March 2005 Hawley et al.
D503797 April 2005 Tyce
D505490 May 2005 Tyce
D506005 June 2005 Hawley et al.
6932794 August 2005 Giambattista et al.
D516719 March 2006 Turchi et al.
D518175 March 2006 Hardin, Jr. et al.
7018364 March 2006 Giambattista et al.
D520636 May 2006 Hawley et al.
D540465 April 2007 Bainton
D546447 July 2007 White
D548835 August 2007 Galbraith
D550363 September 2007 Hannant et al.
D551341 September 2007 Galbraith
D553681 October 2007 Cetera
D567939 April 2008 Mattigka
D580052 November 2008 White
D580069 November 2008 Lee
7534222 May 2009 Sugita et al.
D598496 August 2009 Ikeda
D598539 August 2009 Tyce
D599008 August 2009 Tyce
D599009 August 2009 Tyce
D599010 August 2009 Tyce
D599011 August 2009 Tyce
D600794 September 2009 Tyce
D600795 September 2009 Tyce
7621891 November 2009 Wyrick
D606649 December 2009 Tyce
D606650 December 2009 Tyce
D608442 January 2010 Tyce
D610251 February 2010 Tyce
D610252 February 2010 Tyce
D610676 February 2010 Tyce
D610677 February 2010 Tyce
D626216 October 2010 Tyce
D641783 July 2011 Lira-Nunez et al.
D650069 December 2011 Mori
D650070 December 2011 Mori
D651305 December 2011 Hawley et al.
D652136 January 2012 Hawley et al.
D661352 June 2012 Lira-Nunez et al.
D685464 July 2013 Sanders
D687544 August 2013 Stephan et al.
2004/0106895 June 2004 Slate et al.
2004/0236284 November 2004 Hoste et al.
2005/0187523 August 2005 Giambattista et al.
2005/0234492 October 2005 Tsai et al.
2005/0251103 November 2005 Steffen et al.
2006/0155246 July 2006 Higuchi et al.
2006/0229570 October 2006 Lovell et al.
2007/0123829 May 2007 Atterbury et al.
2007/0129687 June 2007 Marshall et al.
2009/0076458 March 2009 Nielsen et al.

Other References

Article on www.diabeteshealth.com about FDA approval of Lantus SoloStar disposable insulin pen, with a picture of the product, dated May 4, 2007 (5 pages). cited by applicant .
DCA brochure for SoloStar disposable pen injector for insuling, as found on www.effectivedesign.org.uk, dated Jun. 2, 2009 (10 pages). Reference to date of product launch (2007) on p. 2, last paragraph. cited by applicant .
SoloStar disposable pen injector by DCA Design International for Sanofi Aventis GmbH, as shows on www.effectivedesign.org.uk, dated Oct 22, 2009 (3 pages). cited by applicant.

Primary Examiner: Windmuller; John
Attorney, Agent or Firm: McDonnell Boehnen Hulbert & Berghoff LLP

Description



The file of this patent contains at least one photograph executed in color. Copies of this patent with color photographs will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 is a right side view of the medical injector of our new design:

FIG. 2 is a front view thereof,

FIG. 3 is a left side view thereof;

FIG. 4 is a rear view thereof;

FIG. 5 is a perspective thereof;

FIG. 6 is a top view thereof; and

FIG. 7 is a bottom view; and,

FIG. 8 is a bottom perspective view.

The colors of the design are as follows:

Cap: sky blue;

Body: sky blue;

Dose dial grip: light blue-gray; and

Dose button: royal blue.

* * * * *

References


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed